D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
CALL
Ambarella
AMBA
$2.99B
| $251K | ﹤0.01% |
+5,800
| New | +$229K |
|
|
CUK
3252
DELISTED
Carnival PLC
CUK
| $250K | ﹤0.01% |
5,018
-140,477
| -97% | -$7.68M |
|
3253
German American Bancorp
GABC
$1.82B
| $250K | ﹤0.01% |
+8,490
| New | +$256K |
|
|
MIXT
3254
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $250K | ﹤0.01% |
+14,986
| New | +$257K |
|
3255
Alamo Group
ALG
$2.01B
| $249K | ﹤0.01% |
+2,493
| New | +$225K |
|
3256
CALL
ONE Gas
OGS
$5.05B
| $249K | ﹤0.01% |
+2,800
| New | +$235K |
|
|
ACGN
3257
DELISTED
Aceragen Inc
ACGN
| $249K | ﹤0.01% |
5,759
+2,586
| +82% | +$125K |
|
|
SLAI
3258
DELISTED
SOLAI Ltd ADS
SLAI
| $247K | ﹤0.01% |
253
-186
| -42% | -$177K |
|
3259
PUT
Ollie's Bargain Outlet
OLLI
$4.01B
| $247K | ﹤0.01% |
+2,900
| New | +$234K |
|
|
WPRT
3260
Westport Fuel Systems
WPRT
$36.5M
| $247K | ﹤0.01% |
+15,932
| New | +$233K |
|
3261
PUT
Beazer Homes USA
BZH
$907M
| $246K | ﹤0.01% |
21,400
-25,500
| -54% | -$305K |
|
3262
Cleveland-Cliffs
CLF
$6.81B
| $246K | ﹤0.01% |
24,669
-3,360,695
| -99% | -$33.6M |
|
3263
Rafael Holdings
RFL
$111M
| $246K | ﹤0.01% |
19,752
-100,229
| -84% | -$1.44M |
|
|
PVLA
3264
Palvella Therapeutics
PVLA
$1.98B
| $246K | ﹤0.01% |
917
+293
| +47% | +$69.6K |
|
3265
PUT
AptarGroup
ATR
$8.45B
| $245K | ﹤0.01% |
2,300
| – | – |
|
3266
PUT
The Greenbrier Companies
GBX
$1.61B
| $245K | ﹤0.01% |
+7,600
| New | +$303K |
|
3267
CALL
Applied Optoelectronics
AAOI
$8.04B
| $244K | ﹤0.01% |
+20,000
| New | +$302K |
|
3268
Xcel Energy
XEL
$51B
| $244K | ﹤0.01% |
4,342
-102,172
| -96% | -$5.43M |
|
3269
Aaon
AAON
$8.41B
| $243K | ﹤0.01% |
7,883
-33,520
| -81% | -$880K |
|
3270
Gorman-Rupp
GRC
$2.16B
| $242K | ﹤0.01% |
+7,138
| New | +$241K |
|
3271
Penske Automotive Group
PAG
$14.3B
| $242K | ﹤0.01% |
5,425
-16,097
| -75% | -$713K |
|
|
USX
3272
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $242K | ﹤0.01% |
36,675
+7,312
| +25% | +$56.8K |
|
|
GRA
3273
CALL
DELISTED
W.R. Grace & Co.
GRA
| $242K | ﹤0.01% |
+3,100
| New | +$228K |
|
|
BCPC
3274
CALL
Balchem Corp
BCPC
$5.23B
| $241K | ﹤0.01% |
2,600
| – | – |
|
3275
CALL
Equity Lifestyle Properties
ELS
$12.8B
| $240K | ﹤0.01% |
+4,200
| New | +$225K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.